COPD drug accepted by NHS Scotland

Scotland's drug watchdog has accepted a new maintenance therapy for COPD for use in the NHS.

Consultation: GPs in Scotland now have further options for COPD
Consultation: GPs in Scotland now have further options for COPD

The decision by the Scottish Medicines Consortium (SMC) to accept aclidinium widens the choice for GPs treating COPD in adults.

Until now, tiotropium was the only other licensed long-acting muscarinic antagonist (LAMA) accepted for use in NHS Scotland.

Aclidinium, which is inhaled twice daily using the Genuair dry powder inhaler device, was found to improve lung function versus placebo after 12 and 24 weeks.

Results from two RCTs submitted by manufacturer Almirall showed both peak and trough FEV1 improved in the aclidinium group compared with placebo. Side effects were similar or less than with placebo.

A study comparing the six-week clinical effectiveness of aclidinium versus tiotropium is ongoing.

The SMC noted that due to the lower annual cost of aclidinium versus current standard care, the NHS could save over £400,000 within five years as use of the drug increases.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Medico-legal: Intimate examinations and chaperones during COVID-19

Medico-legal: Intimate examinations and chaperones during COVID-19

Remote consultations are likely to be a key part of general practice for months to...

NHS England promises detail on additional flu funding ‘by end of August’

NHS England promises detail on additional flu funding ‘by end of August’

GPs may have to wait until the end of August to find out details of any additional...

Why 63% of GPs expect to do more home-working after COVID-19

Why 63% of GPs expect to do more home-working after COVID-19

Working from home was one of the key issues raised in GPonline's survey of more than...

Lack of support during the menopause leading female doctors to quit

Lack of support during the menopause leading female doctors to quit

A lack of support during the menopause has led some female doctors to consider reducing...

One in three single-handed GPs at high-risk from COVID-19

One in three single-handed GPs at high-risk from COVID-19

A third of single-handed GPs are at high-risk from COVID-19, which could potentially...

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Dr Mark Spencer explains how the COVID-19 pandemic helped his primary care network...